While nearly 18% of U.S. adults have taken a GLP-1 drug for weight loss or to treat a chronic condition, about half of people will stop taking it within a year. Often, they don’t understand what is likely to come next. 🔗: https://t.co/4k6wr8fjCf pic.twitter.com/NGHc3JzOJ3— The Wall Street Journal (@WSJ) April 25, 2026
While nearly 18% of U.S. adults have taken a GLP-1 drug for weight loss or to treat a chronic condition, about half of people will stop taking it within a year. Often, they don’t understand what is likely to come next. 🔗: pic.
@WSJ·X: @WSJ··1 min readSubscription
X
Continue reading on X: @WSJ
This article was sourced from X: @WSJ's RSS feed. Visit the original for the complete story.
Subscription required — this source requires an active subscription to read the full article.